408
Participants
Start Date
September 1, 2021
Primary Completion Date
August 1, 2023
Study Completion Date
December 1, 2023
OXO-001
OXO-001 oral administration once daily in the early morning. The treatment duration will vary depending on the woman, but it will last between 10 to 14 weeks approximately.
Placebo
Placebo oral administration once daily in the early morning. The treatment duration will vary depending on the woman, but it will last between 10 to 14 weeks, approximately.
Fertimed s.r.o., Olomouc
ISCARE centrum asistované reprodukce, Prague
IVF CUBE, Prague
Sanatorium PRONATAL, Prague
UNICA Prague s.r.o, Prague
Pronatal NORD, Teplice
Klinika reprodukční medicíny a gynekologie, Zlín
KRIOBANK Centrum Leczenia Niepłodności Ginekologia, Bialystok
ProCrea Swiss IVF Center s.r.o., Katowice
Provita Sp. z o.o., Katowice
VitroLive Sp. z o.o., Szczecin
OVIklinika, Warsaw
Przychodnia Lekarska nOvum, Katarzyna Kozioł, Piotr Lewandowski spółka jawna, Warsaw
Instituto Bernabeu, Alicante
Fertty, Barcelona
Hospital Universitari Dexeus, Barcelona
Hospital Universitario Quirónsalud Barcelona, Barcelona
IVI Barcelona, Barcelona
IVI Bilbao, Leioa
GINEFIV Madrid, Madrid
Hospital Universitario Quirónsalud Madrid, Madrid
Instituto Bernabeu Madrid, Madrid
IVI Madrid, Madrid
IVI Mallorca, Palma de Mallorca
Ginemed Sevilla, Seville
IVI Sevilla, Seville
IVI Valencia, Valencia
IVI Zaragoza, Zaragoza
Lead Sponsor
OXOLIFE
INDUSTRY